{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:43:28Z","timestamp":1785545008571,"version":"3.56.0"},"reference-count":20,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Out-of-pocket (OOP) costs pose a significant barrier to participating in cancer clinical trials (CCTs). Financial reimbursement programs (FRPs) that reduce the burden of OOP costs can support participation in CCTs if the information is readily available to participants at the time of enrollment. Prior studies have shown the importance and impact of FRPs, but despite improvements, significant barriers still remain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study was designed to explore the feasibility and acceptability of automated texts designed to offer, screen, and enroll CCT participants in an FRP for OOP travel and lodging-related clinical trial costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used a mixed methods approach. Eligible participants were those who consented to participate in a breast, leukemia, or chimeric antigen receptor T cell (CAR-T) trial at the Abramson Cancer Center of the University of Pennsylvania, a National Cancer Institute comprehensive cancer center. Quantitative data were collected through engagement metrics, including text response rates and enrollment rates, as well as patient-reported satisfaction scores. Qualitative data were derived from semistructured interviews. Program enrollment rates were used to determine feasibility, whereas the engagement metrics were used to measure the acceptability of the program. Semistructured interviews were conducted with a subsample of patients who responded to at least one of the FRP texts and agreed to be interviewed to determine the barriers to and facilitators of enrolling in the Improving Patient Access to Cancer Clinical Trials (IMPACT) program via text, perceived advantages and disadvantages of the text messaging program compared to a phone call, and overall feedback on the acceptability of the automated text messaging program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Quantitative data, including engagement with texts, FRP eligibility screening, and enrollment rates, were collected from all participants who successfully received a text (n=51), and qualitative data were collected from a subsample of participants who agreed to participate in a semistructured interview (n=28) about the text-based program. Participants\u2019 mean age was 58 (SD 12) years, approximately 65% (n=33) of participants were female, 21% (n=11) of participants were Black, and 4% (n=2) of participants were Hispanic or Latino. There was high engagement with texts (n=49, 96.1%) and a high screening rate for FRP eligibility (n=33, 64.7%). Of those who successfully screened, 26 (51%) screened via text. We also saw high overall FRP enrollment rates of those who completed the texts (n=16 of 24 eligible, 66.7%) and high satisfaction (Net Promoter Score=51). The text-based platform streamlined the enrollment process, allowing one-third of patients to complete enrollment independently, without assistance from the FRP coordinator. Reported facilitators for completion of the text conversation included support from the coordinator and introduction of the FRP by CCT teams. Barriers were a lack of communication from CCT teams, patient skepticism about the legitimacy of the texts, and limited program information via text.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite the small sample size and single study site, these findings suggest that automated text messaging can be an effective, low-cost, and scalable strategy to increase awareness and streamline enrollment in FRPs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/78916","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:20:05Z","timestamp":1758525605000},"page":"e78916-e78916","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and Acceptability of Automated Texts to Offer, Screen, and Enroll Patients in a Cancer Clinical Trial Financial Reimbursement Program: Mixed Methods Study"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2311-8323","authenticated-orcid":false,"given":"Ashley E","family":"Santaniello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7747-5459","authenticated-orcid":false,"given":"Hena","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5491-899X","authenticated-orcid":false,"given":"Sarah","family":"Milinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8556-3846","authenticated-orcid":false,"given":"Mohan","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9795-2683","authenticated-orcid":false,"given":"Vivian","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-1128","authenticated-orcid":false,"given":"E Paul","family":"Wileyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7252-954X","authenticated-orcid":false,"given":"Robert H","family":"Vonderheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-9229","authenticated-orcid":false,"given":"Dana","family":"Dornsife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3271-4916","authenticated-orcid":false,"given":"Robert G","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6349-9142","authenticated-orcid":false,"given":"Carmen E","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"2","key":"R1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/1055-9965.EPI-19-0460","article-title":"Medical financial hardship intensity and financial sacrifice associated with cancer in the United States","volume":"29","author":"Han","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ijgc-2021-002475","article-title":"Evaluating meaningful levels of financial toxicity in gynecologic cancers","volume":"31","author":"Esselen","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"R3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial burdens of cancer treatment: a systematic review of risk factors and outcomes","volume":"17","author":"Smith","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"R4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"R5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/onco.13767","article-title":"Patient-reported out-of-pocket costs and financial toxicity during early-phase oncology clinical trials","volume":"26","author":"Huey","journal-title":"Oncologist"},{"issue":"6 Suppl 5","key":"R6","doi-asserted-by":"publisher","first-page":"S489","DOI":"10.1016\/j.amepre.2015.09.002","article-title":"Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012","volume":"49","author":"Guy","journal-title":"Am J Prev Med"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1634\/theoncologist.2015-0068","article-title":"Recognizing the financial burden of cancer patients in clinical trials","volume":"20","author":"Nipp","journal-title":"Oncologist"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2012.45.4553","article-title":"Patient income level and cancer clinical trial participation","volume":"31","author":"Unger","journal-title":"J Clin Oncol"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1634\/theoncologist.2015-0481","article-title":"Financial burden of cancer clinical trial participation and the impact of a cancer care equity program","volume":"21","author":"Nipp","journal-title":"Oncologist"},{"issue":"6","key":"R10","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1200\/OP.21.00328","article-title":"Implementation of a multisite financial reimbursement program in cancer clinical trials integrated with patient navigation: a pilot randomized clinical trial","volume":"18","author":"Borno","journal-title":"JCO Oncol Pract"},{"issue":"16_suppl","key":"R11","doi-asserted-by":"publisher","first-page":"e18641","DOI":"10.1200\/JCO.2023.41.16_suppl.e18641","article-title":"Barriers and facilitators to enrolling in a cancer clinical trial financial reimbursement program","volume":"41","author":"Nguyen","journal-title":"JCO"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-342","article-title":"Text messaging: an innovative method of data collection in medical research","volume":"3","author":"Kew","journal-title":"BMC Res Notes"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"R14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1302\/0301-620X.96B5.32434","article-title":"Assessing treatment outcomes using a single question: the Net Promoter Score","volume":"96-B","author":"Hamilton","journal-title":"Bone Joint J"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ausmj.2017.12.001","article-title":"Are promoters valuable customers? An application of the Net Promoter Scale to predict future customer spend","volume":"26","author":"Mecredy","journal-title":"Australasian Marketing Journal"},{"key":"R16","unstructured":"Strauss A . Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Sage Publications, Inc; 1990:270."},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","journal-title":"Implement Sci"},{"issue":"3","key":"R18","doi-asserted-by":"publisher","DOI":"10.1056\/cat.24.0201","article-title":"A text message intervention to minimize the time burden of cancer care","volume":"6","author":"Bange","journal-title":"NEJM Catal Innov Care Deliv"},{"issue":"14","key":"R19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143542","article-title":"Text messaging in cancer-supportive care: a systematic review","volume":"13","author":"Wijeratne","journal-title":"Cancers (Basel)"},{"key":"R20","unstructured":"Richwine C . Individuals\u2019 access and use of patient portals and smartphone health apps, 2024. Assistant Secretary for Technology Policy Data Brief; 2025. URL: https:\/\/www.healthit.gov\/sites\/default\/files\/2025-06\/2024-HINTS-Patient-Access-DB77_508.pdf [Accessed 05-09-2025]"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e78916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:26:51Z","timestamp":1785536811000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e78916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2196\/78916","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"v10i2e78916"}}